Seed vs Series A: what actually changes between rounds

Seed and Series A are stages along a continuum, but the differences are sharp at the mechanical and governance level. Seed rounds today often raise USD 1-5 million on SAFEs or notes against early traction and team. Series A is a priced round, typically USD 5-20 million, on full preferred stock documentation, with a board seat for the lead investor and protective provisions that bind the company for years. Founders who treat them as 'just a bigger seed' get surprised by the obligations.

Seed median valuations in 2024-25 ranged broadly: pre-seed at USD 5-15 million post-money, seed at USD 15-40 million post-money. Series A valuations cluster at USD 30-80 million post-money depending on geography and sector. Dilution at seed typically 15-25%, at Series A 18-25%. Add option pool top-up (commonly required pre-money by the lead investor), and founder dilution at Series A can effectively be 25-30%. Compound this across seed and Series A: founders often hold 40-55% combined by Series A close, depending on co-founder count.

Seed SAFE: one or two pages, valuation cap, discount, MFN. Series A term sheet: 5-12 pages covering preferred stock terms, 1x non-participating liquidation preference (standard), anti-dilution (broad-based weighted average), pro-rata rights, information rights, board composition, protective provisions (vetos on key actions like new financings, M&A, executive comp), drag-along and tag-along rights, IPO conversion, founder vesting (often reset to 4-year vest with 1-year cliff from financing close). Term sheets are not legally binding but commit founders to the shape of the round. Read every line.

Seed: usually no board seat or an observer right; founder runs the company with informal counsel. Series A: lead investor takes a board seat, often a second investor seat, and an independent director may be added, making a typical 3- or 5-person board (founders, investors, independent). Protective provisions require investor approval for major decisions: new financings, M&A, dividends, share buybacks, executive compensation above thresholds, debt above thresholds, related-party transactions. Board meetings monthly or quarterly, with formal materials, minutes, and resolutions.

Seed: a team they can back, a problem they believe in, an MVP showing the team can ship, and early validation (waitlists, design-partners, early revenue). Metrics are noisy but improving month-over-month. Series A: a working product with paying customers, USD 1-3 million in ARR for SaaS or equivalent revenue traction, a sales motion that has been replicated more than once, retention curves that don't decay, and a 24-month plan to USD 5-10 million ARR. The Series A bar is higher than a year ago; many founders raise extended seed rounds rather than under-prove the Series A.

How much can I expect to raise at seed and Series A?
Seed rounds typically range from USD 1 million to USD 5 million globally. Series A rounds range from USD 5 million to USD 20 million, with median around USD 10-12 million in 2024-25. Numbers vary by sector and geography.

What is the typical dilution at each stage?
Seed: 15-25% sold. Series A: 18-25% sold, plus an option-pool top-up that comes from pre-money (effectively another 5-10% founder dilution). Combined seed + Series A dilution often 35-45% of pre-funding equity.

Do I need a board at seed?
Most seed investors do not take board seats; observer rights are common. Some leads do take a seat. By Series A, a formal board with the lead investor is standard, often expanded to 3 or 5 directors with one or two independents.

When does the option pool come into the discussion?
At every priced round. Lead investors typically require an option pool top-up of 10-15% pre-money before their investment, ensuring dilution from new hires falls on existing shareholders, not the new investor. Negotiate the size against the actual hiring plan.

What are protective provisions?
Veto rights for preferred shareholders over specified corporate actions: new financings, M&A, asset sales, dividends, debt above thresholds, executive compensation, related-party transactions, board composition changes. They survive until the IPO conversion or share buyback.

Is my SAFE converted at Series A favourable to me?
It depends on the valuation cap versus Series A pre-money. If the cap is lower than the Series A pre-money, SAFE investors convert at the cap (cheaper per share than Series A investors). If the cap is higher, SAFE converts at the discounted Series A price.